Prevalence of end of treatment RNA-positive/sustained viral response in HCV patients treated with sofosbuvir combination therapies

BACKGROUND: Some chronic hepatitis C virus (HCV), genotype 1 infected patients treated with direct antiviral agents (DAAs) remain viremic at end of treatment (EOT+), yet go on to achieve sustained virological response 12 weeks after completion of therapy (SVR(12)). The incidence of EOT+/SVR in patie...

Full description

Saved in:
Bibliographic Details
Published in:Therap Adv Gastroenterol
Main Authors: Malespin, Miguel, Benyashvili, Tamara, Uprichard, Susan L., Perelson, Alan S., Dahari, Harel, Cotler, Scott J.
Format: Artigo
Language:Inglês
Published: SAGE Publications 2016
Subjects:
Original Research
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5330612/
https://ncbi.nlm.nih.gov/pubmed/28286560
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756283X16672392
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items